Recombinant Proteins
Product List
DAP Human
Death-Associated Protein Human Recombinant
DAP is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Osteocrin Human
Osteocrin Human Recombinant
Osteocrin Human, HEK
Osteocrin Human Recombinant, HEK
Osteocrin Human Recombinant is a single, glycosylated, polypeptide chain (28-133 a.a) containing a total of 112 amino acids and having a molecular mass of 12.5 kDa.
Osteocrin is fused to a 6 a.a His-Tag at C-terminus and is purified by proprietary chromatographic techniques.
DBI Human
DBI Human Recombinant
DBI Mouse
Diazepam Binding Inhibitor Mouse Recombinant
DBI Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 110 amino acids (1-87 a.a) and having a molecular mass of 12.4kDa. DBI is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Ostreolysin
Ostreolysin Pleurotus Ostreatus Recombinant
Pleurotus Ostreatus Ostreolysin Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 137 amino acids and having a molecular mass of 15 kDa.
The Ostreolysin is purified by proprietary chromatographic techniques.
DBR1 Human
Debranching RNA Lariats 1 Human Recombinant
DBR1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
OVCA2 Human
Ovarian Tumor Suppressor Candidate 2 Human Recombinant
OVCA2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
OXLD1 Human
Oxidoreductase-Like Domain Containing 1 Human Recombinant
OXLD1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
DCAF7 Human
DDB1 and CUL4 Associated Factor 7 Human Recombinant
DCAF7 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 298 amino acids (19-295 a.a) and having a molecular mass of 33.6kDa.
DCAF7 is fused to a 21 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Introduction
The term “Other” can be defined in various contexts. In a general sense, it refers to something or someone that is different or distinct from the one already mentioned or known . In biological taxonomy, classification involves organizing living organisms into hierarchical categories based on their characteristics and evolutionary history .
Biological properties of “Other” can be understood through key characteristics shared by living organisms, such as order, sensitivity or response to stimuli, reproduction, growth and development, regulation, homeostasis, and energy processing . These properties are expressed in various patterns and distributed across different tissues, contributing to the organism’s overall function and survival.
The primary biological functions of “Other” include catalyzing chemical reactions, synthesizing and repairing DNA, transporting materials across cells, receiving and sending chemical signals, responding to stimuli, and providing structural support . These functions play crucial roles in immune responses and pathogen recognition, ensuring the organism’s defense mechanisms are active and effective .
Modes of action describe the functional or anatomical changes resulting from exposure to a substance. This includes the interaction with other molecules and cells, binding partners, and downstream signaling cascades . For example, a mode of action could involve binding to DNA, leading to transcriptional regulation .
Regulatory mechanisms control the expression and activity of “Other” through transcriptional regulation and post-translational modifications . These mechanisms ensure that the biological processes are carried out efficiently and accurately, adapting to the organism’s needs and environmental changes.
In biomedical research, “Other” has various applications, including diagnostic tools and therapeutic strategies . For instance, understanding the biological properties and functions of different molecules can lead to the development of new treatments and diagnostic methods, improving healthcare outcomes.
